Compare HPF & DH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HPF | DH |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 349.4M | 283.1M |
| IPO Year | 2002 | 2021 |
| Metric | HPF | DH |
|---|---|---|
| Price | $15.89 | $1.19 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $3.43 |
| AVG Volume (30 Days) | 32.2K | ★ 361.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.28 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $241,521,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.41 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.56 | $1.07 |
| 52 Week High | $17.13 | $4.70 |
| Indicator | HPF | DH |
|---|---|---|
| Relative Strength Index (RSI) | 33.89 | 25.03 |
| Support Level | $15.55 | $1.07 |
| Resistance Level | $16.25 | $2.96 |
| Average True Range (ATR) | 0.10 | 0.11 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 18.59 | 20.72 |
John Hancock Preferred Income Fund II is the United States based closed-end, diversified management investment company. Its primary objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. The fund's principal investment strategies include to invests a majority of its assets in preferred stocks and other preferred securities, including convertible preferred securities. Its portfolio composition consists of U.S preferred securities, common stocks, foreign preferred securities, corporate bonds, capital preferred securities and short-term investments.
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.